Allspring Global Investments
XENE icon

Allspring Global Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Allspring Global Investments’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Sell
234,412
-11,894
-5% -$660K 0.02% 625
2026
Q1 		$14M Buy
+246,306
New +$11.3M 0.02% 605

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allspring Global Investments's XENE Position: Q2 2026 in Review

Allspring Global Investments reduced its Xenon Pharmaceuticals (XENE) stake by 4.8% in Q2 2026, selling an estimated $660K and leaving 234,412 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #625.

Allspring Global Investments first reported a position in XENE in Q1 2026 and has held it in 2 quarters since. 169 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Allspring Global Investments held 234,412 shares of Xenon Pharmaceuticals worth $14.1M as of Q2 2026.
  • Allspring Global Investments sold 11,894 Xenon Pharmaceuticals shares in Q2 2026, an estimated $660K.
  • Xenon Pharmaceuticals made up 0.02% of Allspring Global Investments's portfolio in Q2 2026, its #625 holding.
  • Allspring Global Investments first reported a position in Xenon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 169 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.